The Top FCA Decisions of 2015 for Government Contractors
Client Alert | 1 min read | 02.16.16
From the Supreme Court’s decision rejecting the applicability of the Wartime Suspension of Limitations Act to several rulings widening the circuit split on the implied certification theory of liability, 2015 saw a number of important False Claims Act case law developments. In a "Feature Comment" published in The Government Contractor, C&M attorneys highlight the top ten decisions from 2015 on key issues—such as damages calculations, original source requirements, statistical sampling, and more—that will shape this ever-active area of litigation in 2016 and beyond.
Contacts
Insights
Client Alert | 3 min read | 01.21.26
Atlantic Biologicals Opioid DPA: DOJ Continues Ramp Up of Criminal Corporate Healthcare Enforcement
On January 13, 2026, Miami-based pharmaceutical wholesaler Atlantic Biologicals Corporation entered into a two-year DPA, admitting to conspiracy to distribute and dispense controlled substances, including more than 14 million opioid doses to “pill mill” pharmacies in Texas at a markup. The DOJ and DEA underscored the company’s deliberate evasion of compliance checks and disregard for red flags signaling diversion.
Client Alert | 3 min read | 01.21.26
FedRAMP Proposes Updates to Authorization Process—Six New RFCs Released for Public Comment
Client Alert | 3 min read | 01.20.26
DoW Joins SBA’s Fight Against Alleged Pass-Through Fraud in the 8(a) Program
Client Alert | 3 min read | 01.20.26
Federal Government Challenges Minnesota Law Requiring Affirmative Action in State Government
